HotelPlanner CEO Tim Hentschel on Their 3-Way SPAC Merger with Reservations.com and Astrea Acquisition (ASAX)

by | Dec 20, 2021

HotelPlanner / Reservations.com / Astrea (ASAX) Deal Overview

HotelPlanner and Reservations.com are going public in a three-way merger with Astrea Acquisition Corp (ASAX) in a $567M EV deal that was announced in August 2021.  

HotelPlanner is different from many of the traditional, more recognized online travel agents (OTAs) in that Hotelplanner’s primary focus is group booking, i.e. large room blocks of 9+ rooms, of which they are the leader in the space. In addition, Hotelplanner partners with the OTAs / other affiliates, and touts its proprietary AI-engine as unique and best in class.  

“Closed User Group” discount rates are Hotelplanner’s biggest differentiator. The company negotiates discounted rates with its 50k hotel network for all types of group events including weddings, conferences meetings, and keeps those rates unpublished. This allows for higher-margin and fewer cancellations. HotelPlanner partners with OTAs and affiliates (e.g. The Knot) to drive this offering. 

HotePlanner utilizes so called “gig-based travel agents” to provide local, personal customer service and assistance to customers looking to book their hotels. Only needing “WiFi and a headset” the gig agents allow for a scalable and flexible complimentary customer service experience for customers. The company feels local city experts are more effective than an outsourced (often overseas) call center.  

HotelPlanner forecasts revenue to grow from $128M in 2021 out to $273M in 2024E, and expects EBITDA margin to grow from 5% to 19% over the same time period. In addition, the company says it’s tracking well above its 2019 (pre-COVID) revenue and profitability markers. Growth to be driven in part by synergies stemming from Reservations.com integration, both cost and revenue synergies ($13M and $11M respectively for 2022).  

Competitive Landscape + Valuation 

HotelPlanner competes with many of the traditional OTAs including Expedia (EXPE), Trivago (TVGO), and Booking.com (BKNG). However, they also partner with the OTAs given HotelPlanner’s main focus on group booking, which isn’t necessarily the same for the traditional players, i.e. individuals or families booking trips and < 9 rooms for the trip.  

HotelPlanner’s revenue declined just 23% in 2020 (mid pandemic) which was less than the >50% for many of their competitors and other players in the travel and booking space. The company contends that had their gig program have been rolled out, the decline would have been smaller.  

The transaction values HotelPlanner at $567M EV which equates to 4.45x 2021E revenue and 3.34x 2022E revenue. That puts them at a 2022 premium to EXPE (3.1x) Despegar (2.5x) and Trivago (2.1x) but a discount to the comparable median and BKNG (8.7x) and TRIP (5.9x).  

Deal Details 

Hentschel mentions that the company had several SPAC offers, including some at a $200-300M higher valuation, but chose to go with Astrea Acquisition given some of management’s previous SPAC history and provide a more attractive entry point for investors.  

HotelPlanner intends to use the cash infusion from the deal will be used towards search engine marketing spend and growing the engineering department. ASAX has ~$172.6M in its trust account, but notably the deal financing does not include a PIPE. Therefore, if SPAC market dynamics stay the way they currently are, namely discounted SPACs and high redemptions, ASAX’s $9.89 closing price would certainly put this deal at risk of high redemptions.  

The merger agreement has a minimum cash requirement of $100M, so there is a possibility that would have to be waived or the company seek incremental financing in between now and deal close, which is expected some time next year (company would not provide an estimate).  

Both HotelPlanner.com and Reservations.com are essentially bootstrapped from founding and the 4 founders are set to own ~70% of the PF combined company. 

About the SPAC Sponsor

The SPAC behind the HotelPlanner deal is Astrea Acquisition Corporation (ASAX). ASAX raised $172.5M in a February IPO, offering unit holders 1/2 of a warrant, and didn’t specify a target area of focus.  

Led by CEO Felipe Gonzalez (PM of London-based Strongrock Capital) and CFO Jose Luis Cordovda (PM at Axis Capital Mgmt), this is the first SPAC specifically sponsored by this team. 

However, Cordova was previous the CFO of Opes Acquisition Corp (OPES) who de-spac’ed into BurgerFi (BFI) in December 2020. BFI had been performing very well but shares have lagged significantly in months most recently closing <$7 at $6.63.  

About Tim Hentschel  

Tim is a third generation hotelier who’s worked in the hospitality industry since he was 12 and graduated from the renowned Cornell hotel program. Studying in the late 90s/early 2000s Tim always had an eye for how technology could help solve pain points in travel and booking, which serves as the ethos and mission of HotelPlanner.  

<a href="https://www.boardroomalpha.com/author/draps/" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – July 2022

Liquidations, cancelled deals, and a dead IPO market highlight Boardroom Alpha’s July 2022 SPAC market review. Read for a full recap.

SPAC Market Review – June 2022

Boardroom Alpha’s June 2022 SPAC market review looks at the latest trends in SPACs, where the market is heading a recap of activity.

SPAC Market Review – May 2022

Inflation, rising interest rates, and reduced corporate earnings across the board have led to persistent market gyrations which prove its too early for bottom fishing. The stampede out of deSPACs now makes it ‘deal-or-die’ time for those without targets.

SPAC Research & Analysis

Boardroom Alpha Digest: Mon, Jan 9

Rite Aide Corporation (RAD) parts ways with Heyward Donigan and Paya Holdings (PAYA) acquisition highlight Monday’s daily digest.

Boardroom Alpha Digest: Thurs, Jan 5

Boardroom Alpha’s Daily Digest highlights include Elizabeth Spaulding resigning as CEO of Stitch Fix (SFIX) and JNJ’s Kenvue filing for an IPO

SPAC Market Review – December 2022

December’s SPAC market review takes a look by the numbers of the month’s SPAC activity and how the market currently stands going into 2023.

SPACs Today: Wednesday, Dec 14

Rice Acquisition Corp. II (RONI) with an encouraging energy transaction, and the rest of the day’s SPAC news.

SPACs Today: Monday, Dec 12

Venus Acquisition Corporation (VENA) finally closed and changes ticker to MLGO, and the rest of the day’s SPAC news.

SPAC Market Review – November 2022

November’s SPAC market review paints a picture of a SPAC market rushing towards the exit with high, and accelerating liquidations, more deal terminations, and almost no new SPAC IPOs.

Know Who Drives Return Podcast

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. WindAcre increases its stake and opposes NSLN takeover bid. Activist Jana Partners brings lessons learned at ConAgra (CAG) to Treehouse Foods (THS). And other notable special situations.

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. Management shakeup at Faraday Future (FIFE) is an all-too familiar story in the world of EV SPACs. Blackrock to be 75% net-zero aligned by 2030, and Jana closing in (again) at Treehouse Foods (THS).

FOXO Technologies CEO Jon Sabes Is About to Disrupt the Insurance Industry

Boardroom Alpha talks to Jon Sabes, CEO of FOXO Technologies, which announced a SPAC merger with sponsor Delwinds Insurance Acquisition Corp. (DWIN). Sabes explains how epigenetic biomarkers can change the game for life insurance companies and tell us more about health and wellness than ever before.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.